Navigation Links
Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
Date:1/30/2008

IRVING, Texas, Jan. 30 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) said it retained Milkie/Ferguson Investments, Inc. as its financial advisor to assist it in exploring a range of financial alternatives.

"Our hiring of a financial advisor is a continuation of our efforts to thoroughly consider our business model and all opportunities going forward," said Carlton Turner, PhD, chief executive officer of Carrington. "We have valuable technologies and assets which we believe have significant emerging potential and we look forward to working with Milkie/Ferguson on these initiatives."

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's DelSite Biotechnologies subsidiary is developing its proprietary GelSite(R) polymer technology designed to provide controlled release of peptide and protein-based drugs. A second technology Gelvac(TM) is designed for dry powder nasal delivery of vaccines without the need for preservatives, adjuvants, cold storage and shipping under cold conditions. One influenza vaccine, (H1N1 antigen) with this technology, has been stable for more than three years at room temperature.

Carrington's technology is protected by more than 130 patents in 26 countries. Select products carry the CE mark, recognized by more than 20 countries around the world. For more information, visit http://www.carringtonlabs.com.

About Milkie/Ferguson

Milkie/Ferguson Investments is a full-service, FINRA- and SIPC-member broker-dealer and boutique investment bank specializing in financing, fairness opinions, valuations, mergers and acquisitions. Milkie/Ferguson is distinguished by putting the client's interest first, providing senior-level attention, maximizing client value, and providing the premium level of service of top-tier investment banks. Milkie/Ferguson draws on its broad foundation and experience to create a tailored approach for each client that results in success. Among the firm's more recent engagements was as advisor to Reddy Ice Holdings, Inc on the $20 million sale of businesses unrelated to its bagged- ice focus.

Certain statements in this release concerning Carrington may be forward- looking. Actual events will be dependent upon a number of factors and risks including, but not limited to: subsequent changes in plans by the Company's management; delays or problems in formulation, manufacturing, distribution, production and/or launch of new finished products; changes in the regulatory process; changes in market trends; and a number of other factors and risks described from time to time in the Company's filings with the Securities & Exchange Commission.

For Information Contact:

Robert Schnitzius, Chief Financial Officer

(972) 518-1300


'/>"/>
SOURCE Carrington Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Reports Third Quarter 2007 Results
2. Carrington Reports on ISO 9001:2000 Inspection
3. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
4. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
7. Carrington Completes $8 Million Financing
8. Carrington Reports Second Quarter 2007 Results
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
11. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... MedDay, a biotechnology company focused on ... of Catherine Moukheibir as Chairman of its Board of Directors. ... Jacques Garaud , who contributed to the rapid development of ... Catherine started her career in strategy consulting and investment ... London .  She held C-Suite level roles in some ...
(Date:4/26/2016)... ... April 27, 2016 , ... Cameron ... LLP as an associate in the firm’s Intellectual Property practice group. , Clients ... electromechanical patent applications. He has an electrical engineering and computer engineering background, and ...
(Date:4/26/2016)... ... 26, 2016 , ... The European Patent Office (EPO) today announced ... finalists for the European Inventor Award 2016 in the category "Non-European countries." The winners ... a ceremony in Lisbon on June 9th. , The human capacity to walk with ...
(Date:4/26/2016)... ... 2016 , ... Mr. Palmer created the RPO business for Ceridian and lead ... managed services contract in the U.S. intelligence community with The SI (a Lockheed Martin ... Younger, founder of Accolo. “We are growing and his experience guiding our expansion ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):